BRAINLIFE.ORG
|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
26 Number 13
10 July 2024
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
26, Year 2024 >
Number 13, 10 July
|
|
|
|
|
|
Miramova A, Gartner A, Ivanov D.
How
to sensitize glioblastomas to temozolomide chemotherapy: a
gap-centered view.
Front
Cell Dev Biol. 2024 Jul 1;12:1436563. doi:
10.3389/fcell.2024.1436563. PMID:
39011394. Review. ˍ
|
|
|
|
Menna
G, Marinno S, Valeri F, Mahadevan S, Mattogno PP, Gaudino S, Olivi
A, Doglietto F, Berger MS, Della Pepa GM.
Diffusion
tensor imaging in detecting gliomas sub-regions of infiltration,
local and remote recurrences: a systematic review.
Neurosurg
Rev.
2024 Jul 2;47(1):301. doi:
10.1007/s10143-024-02529-3. PMID:
38954077. Review˰ ˍ
|
|
|
|
Palizkaran
Yazdi M, Barjasteh A, Moghbeli M.
MicroRNAs
as the pivotal regulators of Temozolomide resistance in
glioblastoma.
Mol
Brain.
2024 Jul 2;17(1):42. doi:
10.1186/s13041-024-01113-6. PMID:
38956588. Review. ˍ
|
|
|
|
Sepulveda F, Scotto Opipari R, Coppola F, Ramaglia A, Mankad K,
Alves CAP, Bison B, Löbel U.
Approaches
to supratentorial brain tumours in children.
Neuroradiology.
2024 Jul 2. doi:
10.1007/s00234-024-03398-9. PMID:
38953989. Review˰
ˍ
|
|
|
|
Wei
S, Chang L, Zhong Y.
The
efficacy and adverse events of bevacizumab combined with
temozolomide in the treatment of glioma: a systemic review and
meta-analysis of randomized controlled trials.
Front
Med (Lausanne).
2024 Jul 2;11:1419038. doi:
10.3389/fmed.2024.1419038. PMID:
39015784. Review; Meta-analysis. ˍ
|
|
|
|
Baker
CR, Pease M, Sexton DP, Abumoussa A, Chambless LB.
Artificial
intelligence innovations in neurosurgical oncology: a narrative
review.
J
Neurooncol.
2024 Jul 3. doi:
10.1007/s11060-024-04757-5. PMID:
38958849. Review. ˍ
|
|
|
|
Chatterjee
D, Bhattacharya S, Kumari L, Datta A.
Aptamers:
ushering in new hopes in targeted glioblastoma therapy.
J
Drug Target.
2024 Jul 3:1-24. doi:
10.1080/1061186X.2024.2373306. PMID:
38923419. Review˰ ˍ
|
|
|
|
McBriar JD, Shafiian N, Scharf S, Boockvar JA, Wernicke AG.
Prostate-Specific Membrane Antigen Use
in Glioma Management: Past, Present, and Future.
Clin
Nucl Med. 2024 Jul 3. doi:
10.1097/RLU.0000000000005365. PMID:
38968568. Review˰ ˍ
|
|
|
|
Tataranu LG, Turliuc S, Rizea RE, Dricu A, Alexandru O, Staicu GA,
Kamel A.
A Synopsis of Biomarkers in
Glioblastoma: Past and Present.
Curr
Issues Mol Biol. 2024 Jul 3;46(7):6903-6939. doi:
10.3390/cimb46070412. PMID:
39057054. Review. ˍ
|
|
|
|
Sheikh
SR, Patel NJ, Recinos VM.
Safety
and Technical Efficacy of Pediatric Brainstem Biopsies: An Updated
Meta-Analysis of 1000+ Children.
World
Neurosurg.
2024 Jul 4:S1878-8750(24)01139-2. doi:
10.1016/j.wneu.2024.06.163. PMID:
38968995. Meta-analysis. ˍ
|
|
|
|
Papadimitrakis D, Perdikakis M, Gargalionis AN, Papavassiliou AG.
Biomarkers in Cerebrospinal Fluid for
the Diagnosis and Monitoring of Gliomas.
Biomolecules.
2024 Jul 5;14(7):801. doi:
10.3390/biom14070801. PMID:
39062515. Review. ˍ
|
|
|
|
Sanvito
F, Castellano A, Cloughesy TF, Wen PY, Ellingson BM.
RANO
2.0 criteria: concepts applicable to the neuroradiologist's
clinical practice.
Curr
Opin Oncol.
2024 Jul 5. doi:
10.1097/CCO.0000000000001077. PMID:
39011735. Review˰ ˍ
|
|
|
|
*Scheepens JCC, Taphoorn MJB,
Koekkoek JAF.
Patient-reported
outcomes in neuro-oncology.
Curr
Opin Oncol. 2024
Jul 5. doi:
10.1097/CCO.0000000000001078. PMID:
38984633. Review.
ˍ
|
|
|
|
Galldiks N, Lohmann P, Friedrich M,
Werner JM, Stetter I, Wollring MM, Ceccon G, Stegmayr C, Krause S,
Fink GR, Law I, Langen KJ, Tonn JC.
PET
imaging of gliomas: Status quo and quo vadis?
Neuro
Oncol. 2024 Jul
6:noae078. doi:
10.1093/neuonc/noae078. PMID:
38970818. Review˰ ˍ
|
|
|
|
Sættem M, Sundstrøm T, Sæle AKM, Mahesparan R.
Review of metastasis to meningiomas
with case examples.
Brain
Spine. 2024 Jul 6;4:102862. doi:
10.1016/j.bas.2024.102862. PMID:
39099765. Case report; Review. ˍ
|
|
|
|
*Ng
ZX, Koh ES, Lee SF, Tan CL, Teo K, Wong A, Lo SS, Vellayappan B.
A
systematic review and meta-analysis informing the role of adjuvant
radiotherapy (RT) in Grade 2 and 3 oligodendroglioma.
J
Clin Neurosci.
2024 Jul 8;126:247-255. doi: 10.1016/j.jocn.2024.06.020? PMID:
38981364. Review; Meta-analysis˰ ˍ
|
|
|
|
Vassantachart
AK, Ehret F, Chen E, Kumar R, Gogineni E, Andraos TY, Sahgal A,
Redmond KJ, Lo SS, Chang EL, Sheehan J, Chao ST, Kim GG, Kresl JJ,
Schulder M, Palmer JD, Gibbs IC, Santacroce A, Shih HA.
A
Case-based Guide for World Health Organization (WHO) Grade 2
Meningioma Radiosurgery and Radiation Therapy from The
Radiosurgery Society.
Pract
Radiat Oncol.
2024 Jul 8:S1879-8500(24)00090-0. doi:
10.1016/j.prro.2024.02.009. PMID:
38970567. Guidelines˰ ˍ
|
|
|
|
Khaboushan
AS, Ohadi MAD, Amani H, Dashtkoohi M, Iranmehr A, Sheehan JP.
Stereotactic
radiosurgery for intraventricular meningioma: a systematic review
and meta-analysis.
Acta
Neurochir (Wien).
2024 Jul 9;166(1):286. doi:
10.1007/s00701-024-06185-w. PMID:
38980438. Review; Meta-analysis. ˍ
|
|
|
|
Li X, Gou W, Zhang X.
Neuroinflammation
in Glioblastoma: Progress and Perspectives.
Brain
Sci. 2024 Jul 9;14(7):687. doi:
10.3390/brainsci14070687. PMID:
39061427. Review. ˍ
|
|
|
|
Librizzi G, Lombardi G, Bertoldo A, Manara R.
Perioperative
imaging predictors of tumor progression and pseudoprogression: A
systematic review.
Crit
Rev Oncol Hematol. 2024 Jul 9;202:104445. doi:
10.1016/j.critrevonc.2024.104445. PMID:
38992848. Review. ˍ
|
|
|
|
Sherman JH, Bobak A, Arsiwala T, Lockman P, Aulakh S.
Targeting
drug resistance in glioblastoma (Review).
Int
J Oncol. 2024 Jul 9;65(2):80. doi:
10.3892/ijo.2024.5668. PMID:
38994761.
Review. ˍ
|
|
|
|
Wang M, Peng Y, Wang Y, Luo D.
Research
Trends and Evolution in Radiogenomics (2005-2023): Bibliometric
Analysis.
Interact
J Med Res. 2024
Jul 9;13:e51347. doi:
10.2196/51347. PMID:
38980713. Bibliometric analysis. ˍ
|
|
|
|
Yin J, Liu G, Zhang Y, Zhou Y, Pan Y, Zhang Q, Yu R, Gao S.
Gender differences in gliomas: From
epidemiological trends to changes at the hormonal and molecular
levels.
Cancer
Lett. 2024 Jul 9;598:217114. doi:
10.1016/j.canlet.2024.217114. PMID:
38992488. Review˰ ˍ
|
|
|
|
Bhanja
D, James JG, McNutt S, Kray K, Rizk E.
Awake
craniotomy in pediatric low-grade glioma: barriers and future
directions.
Childs
Nerv Syst.
2024 Jul 10. doi:
10.1007/s00381-024-06457-x. PMID:
38985318. Review˰ ˍ
|
|
|
|
Rossi
F, Botti S, Morri M, Asaftei S, Bertin D, Breggiè S,
Casalaz R, Cervo M, Ciullini P, Coppo M, Cornelli A, Esposito M,
Ferrarese M, Ghetti M, Longo L, Naretto G, Orsini N, Panzeri D,
Pellegrini C, Peranzoni M, Perna A, Petit N, Picone F, Pittorru G,
Raffa D, Recchiuti V, Rizzato L, Sarzana M, Sensi R, Fagioli F,
Ricci F.
The
Italian Consensus Conference on the role of rehabilitation for
children and adolescents with leukemia, central nervous system
tumors, and bone cancer, part 2: general principles for the
rehabilitation treatment of motor function impairments.
Pediatr
Hematol Oncol.
2024 Jul 10:1-21. doi:
10.1080/08880018.2024.2353360. PMID:
38984654. Meeting report˰ ˍ
|
|
|
|
Shen
S, Wang S, Zhou D, Wu X, Gao M, Wu J, Yang Y, Pan X, Wang N.
A
clinician's perspective on boron neutron capture therapy:
promising advances, ongoing trials, and future outlook.
Int
J Radiat Biol.
2024 Jul 10:1-17. doi:
10.1080/09553002.2024.2373746. PMID:
38986056. Review. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|